BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jones JM, Kracalik I, Levi ME, Bowman JS 3rd, Berger JJ, Bixler D, Buchacz K, Moorman A, Brooks JT, Basavaraju SV. Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020. MMWR Recomm Rep 2020;69:1-16. [PMID: 32584804 DOI: 10.15585/mmwr.rr6904a1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Hendele JB, Limaye AP, Sibulesky L. In with the new and, mostly better: Considering the OPTN blood-borne virus policy updates. Am J Transplant 2021. [PMID: 34008324 DOI: 10.1111/ajt.16688] [Reference Citation Analysis]
2 Schaffhausen CR, Bruin MJ, Chu S, McKinney WT, Lake JR, Chinnakotla S, Israni AK. Designing a Liver Transplant Patient and Family Decision Support Tool for Organ Offer Decisions. Transplant Direct 2021;7:e695. [PMID: 33937520 DOI: 10.1097/TXD.0000000000001140] [Reference Citation Analysis]
3 Czarnecka P, Czarnecka K, Tronina O, Baczkowska T, Durlik M. Utilization of HCV viremic donors in kidney transplantation: a chance or a threat? Ren Fail 2022;44:434-49. [PMID: 35260039 DOI: 10.1080/0886022X.2022.2047069] [Reference Citation Analysis]
4 Srisuwarn P, Sumethkul V. Kidney transplant from donors with hepatitis B: A challenging treatment option. World J Hepatol 2021; 13(8): 853-867 [PMID: 34552692 DOI: 10.4254/wjh.v13.i8.853] [Reference Citation Analysis]
5 Trachuk P, Bartash R, Abbasi M, Keene A. Infectious Complications in Lung Transplant Recipients. Lung 2020;198:879-87. [PMID: 33169174 DOI: 10.1007/s00408-020-00403-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Grossi AA, Nicoli F, De Feo TM, Cardillo M, Biffa G, Pegoraro R, Petrini C, Torelli R, Puoti F, Rossini G, Piccolo G, Vesconi S, Minetti E, Pozzo B, Vanacore G, Paredes D, Grossi PA, Picozzi M. The 3-T Model of Informed Consent for Nonstandard Risk Donors: A Proposal for Transplant Clinical Practice. Transplant Direct 2021;7:e782. [PMID: 34712782 DOI: 10.1097/TXD.0000000000001238] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bixler D, Annambhotla P, Montgomery MP, Mixon-Hayden T, Kupronis B, Michaels MG, La Hoz RM, Basavaraju SV, Kamili S, Moorman A. Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019. MMWR Morb Mortal Wkly Rep 2021;70:961-6. [PMID: 34237046 DOI: 10.15585/mmwr.mm7027a1] [Reference Citation Analysis]
8 Yuan Q, Haque O, Hong S, Ortiz A, Bethea ED, Sise ME, Markmann JF, Elias N. Influence of donor and recipient hepatitis B virus infection on long-term outcomes after kidney transplantation. Clin Transplant 2021;:e14466. [PMID: 34545965 DOI: 10.1111/ctr.14466] [Reference Citation Analysis]
9 Tsujita M, Azhar A, Joglekar K, Talwar M, Balaraman V, Bhalla A, Eason JD, Molnar MZ. The incidence of hepatitis B coinfection after deceased-donor kidney transplantation from hepatitis C infected donors to hepatitis C negative recipients. Transpl Int 2021;34:986-7. [PMID: 33834561 DOI: 10.1111/tri.13877] [Reference Citation Analysis]
10 Roth EM, Haque OJ, Yuan Q, Kotton CN, Markmann JF, Eckhoff DE, Elias N. Heterogeneity in transplant center responses to the minimum acceptance criteria across UNOS regions. Clin Transplant 2021;:e14551. [PMID: 34843130 DOI: 10.1111/ctr.14551] [Reference Citation Analysis]
11 Stehlik J, Mehra MR. Secular changes in organ donor profiles and impact on heart and lung transplantation. J Heart Lung Transplant 2020;39:997-1002. [PMID: 32896477 DOI: 10.1016/j.healun.2020.08.004] [Reference Citation Analysis]
12 Theodoropoulos NM, Greenwald MA, Chin-Hong P, Ison MG. Testing deceased organ donors for infections: An organ procurement organization survey. Am J Transplant 2021;21:1924-30. [PMID: 33621430 DOI: 10.1111/ajt.16552] [Reference Citation Analysis]
13 Theodoropoulos NM, La Hoz RM, Wolfe C, Vece G, Bag R, Berry GJ, Bucio J, Danziger-Isakov L, Florescu DF, Goldberg D, Ho CS, Lilly K, Malinis M, Mehta AK, Nalesnik MA, Sawyer R, Strasfeld L, Wood RP, Michaels MG. Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee. Transpl Infect Dis 2021;23:e13458. [PMID: 32894634 DOI: 10.1111/tid.13458] [Reference Citation Analysis]
14 Kelly YM, Zarinsefat A, Tavakol M, Shui AM, Huang C, Roberts JP. Consent to organ offers from public health service “Increased Risk” donors decreases time to transplant and waitlist mortality. BMC Med Ethics 2022;23. [DOI: 10.1186/s12910-022-00757-0] [Reference Citation Analysis]
15 Pereira MR, Dube GK, Tatem L, Burack D, Crew RJ, Cohen DJ, Ratner LE. HIV transmission through living donor kidney transplant: An 11-year follow-up on the recipient and donor. Transpl Infect Dis 2021;:e13691. [PMID: 34265862 DOI: 10.1111/tid.13691] [Reference Citation Analysis]
16 Kreitman KR, Kothadia JP, Nair SP, Maliakkal BJ. Unexpected hepatitis B virus transmission after liver transplant from nucleic acid testing- and serology-negative liver donors who are hepatitis C viremic. Hepatol Res 2021. [PMID: 34114715 DOI: 10.1111/hepr.13680] [Reference Citation Analysis]
17 Delman AM, Turner KM, Safdar K, Anwar N, Silski LS, Lee TC, Luckett K, Cuffy MC, Quillin RC 3rd, Schoech M, Kaiser TE, Govil A, Bari K, Shah SA. Expanding the Donor Pool: First Use of Hepatitis B Virus Nat Positive Solid Organ Allografts Into Seronegative Recipients. Ann Surg 2021;274:556-64. [PMID: 34506310 DOI: 10.1097/SLA.0000000000005071] [Reference Citation Analysis]
18 Dutch MJ, Patrick CJ, Boan PA, Knott JC, Opdam HI. Prevalence of Blood-Borne Viruses and Predictors of Risk in Potential Organ Donors in Australia. Transpl Int 2022;35:10395. [DOI: 10.3389/ti.2022.10395] [Reference Citation Analysis]
19 Agbim U, Cseprekal O, Yazawa M, Talwar M, Balaraman V, Bhalla A, Podila PSB, Maliakkal B, Nair S, Eason JD, Molnar MZ. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients. Ren Fail 2020;42:767-75. [PMID: 32729359 DOI: 10.1080/0886022X.2020.1798784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lee D, Gramnea I, Seng N, Bruns M, Hudson F, D'Costa R, McEvoy L, Sasadeusz J, O'Leary MJ, Basu G, Kausman JY, Masterson R, Paizis K, Kanellis J, Hughes PD, Goodman DJ, Whitlam JB. Successful Implementation of an Increased Viral Risk Donor Waiting List for Preconsented Kidney Transplant Candidates in Victoria, Australia. Transplant Direct 2021;7:e758. [PMID: 34514113 DOI: 10.1097/TXD.0000000000001211] [Reference Citation Analysis]
21 Ramaswamy K, Madariaga HM, Zheng L, Thomas B, Lerma EV. Donor derived infections in kidney transplant. Disease-a-Month 2022. [DOI: 10.1016/j.disamonth.2022.101330] [Reference Citation Analysis]
22 Kates OS, Stohs EJ, Pergam SA, Rakita RM, Michaels MG, Wolfe CR, Danziger-Isakov L, Ison MG, Blumberg EA, Razonable RR, Gordon EJ, Diekema DS. The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy. Am J Transplant 2021;21:2637-45. [PMID: 33370501 DOI: 10.1111/ajt.16472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]